Ignite Creation Date:
2024-07-17 @ 11:30 AM
Last Modification Date:
2024-10-26 @ 3:33 PM
Study NCT ID:
NCT06478706
Status:
RECRUITING
Last Update Posted:
2024-07-11
First Post:
2024-06-18
Brief Title:
A Two-Part Study to Evaluate the Efficacy Safety Tolerability and Pharmacokinetics of Repeat Doses of Inhaled ETD001 in People With Cystic Fibrosis
Sponsor:
Enterprise Therapeutics Ltd
Organization:
Enterprise Therapeutics Ltd
Organization Data
Organization:
Enterprise Therapeutics Ltd
Class:
INDUSTRY
Study ID:
ET-ENAC-03
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Enterprise Therapeutics Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None